---
title: "Telomir Pharmaceuticals, Inc. (TELO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/TELO.US.md"
symbol: "TELO.US"
name: "Telomir Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
---

# Telomir Pharmaceuticals, Inc. (TELO.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [elomirpharma.com](https://elomirpharma.com) |

## Company Profile

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson’s disease, ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.70 | 151/257 | - | - | - |
| PB | 5.96 | 150/257 | 120.34 | 97.27 | 6.60 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-09-09T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.25 |
| Highest Target | 15.50 |
| Lowest Target | 15.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/TELO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/TELO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/TELO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.